Literature DB >> 22129306

Intrinsic regulation of hemoglobin expression by variable subunit interface strengths.

James M Manning1, Anthony M Popowicz, Julio C Padovan, Brian T Chait, Lois R Manning.   

Abstract

The expression of the six types of human Hb subunits over time is currently considered to be regulated mainly by transcription factors that bind to upstream control regions of the gene (the 'extrinsic' component of regulation). Here, we describe how subunit pairing and further assembly to tetramers in the liganded state is influenced by the affinity of subunits for one another (the 'intrinsic' component of regulation). The adult Hb dimers have the strongest subunit interfaces and the embryonic Hbs the weakest, with fetal Hbs being of intermediate strength, corresponding to the temporal order of their expression. These variable subunit binding strengths and the attenuating effects of acetylation contribute to the differences with which these Hb types form functional O(2) -binding tetramers consistent with gene switching.
© 2011 The Authors Journal compilation © 2011 FEBS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22129306      PMCID: PMC3270300          DOI: 10.1111/j.1742-4658.2011.08437.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  27 in total

1.  The acetylation state of human fetal hemoglobin modulates the strength of its subunit interactions: long-range effects and implications for histone interactions in the nucleosome.

Authors:  L R Manning; J M Manning
Journal:  Biochemistry       Date:  2001-02-13       Impact factor: 3.162

2.  Assembly of gamma- with alpha-globin chains to form human fetal hemoglobin in vitro and in vivo.

Authors:  K Adachi; Y Zhao; T Yamaguchi; S Surrey
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

Review 3.  Cooperative hemoglobins: conserved fold, diverse quaternary assemblies and allosteric mechanisms.

Authors:  W E Royer; J E Knapp; K Strand; H A Heaslet
Journal:  Trends Biochem Sci       Date:  2001-05       Impact factor: 13.807

Review 4.  Structure and function of haemoglobin.

Authors:  J M Baldwin
Journal:  Prog Biophys Mol Biol       Date:  1975       Impact factor: 3.667

Review 5.  Molecular aspects of embryonic hemoglobin function.

Authors:  Thomas Brittain
Journal:  Mol Aspects Med       Date:  2002-08

6.  Measuring assembly and binding in human embryonic hemoglobins.

Authors:  Thomas Brittain
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

7.  Developmental expression of human hemoglobins mediated by maturation of their subunit interfaces.

Authors:  Lois R Manning; Anthony M Popowicz; Julio Padovan; Brian T Chait; J Eric Russell; James M Manning
Journal:  Protein Sci       Date:  2010-08       Impact factor: 6.725

8.  Recombination studies on haemoglobins at neutral pH.

Authors:  E R Huehns; G H Beaven; B L Stevens
Journal:  Biochem J       Date:  1964-08       Impact factor: 3.857

Review 9.  Haemoglobin synthesis during human fetal development.

Authors:  W G Wood
Journal:  Br Med Bull       Date:  1976-09       Impact factor: 4.291

10.  Human hemoglobin Portland II (zeta 2 beta 2). Isolation and characterization of Portland hemoglobin components and their constituent globin chains.

Authors:  Z I Randhawa; R T Jones; L E Lie-Injo
Journal:  J Biol Chem       Date:  1984-06-10       Impact factor: 5.157

View more
  2 in total

1.  Microscopy ambient ionization top-down mass spectrometry reveals developmental patterning.

Authors:  Cheng-Chih Hsu; Nicholas M White; Marito Hayashi; Eugene C Lin; Tiffany Poon; Indroneal Banerjee; Ju Chen; Samuel L Pfaff; Eduardo R Macagno; Pieter C Dorrestein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-22       Impact factor: 11.205

2.  Gel filtration of dilute human embryonic hemoglobins reveals basis for their increased oxygen binding.

Authors:  Lois R Manning; Anthony M Popowicz; Julio C Padovan; Brian T Chait; James M Manning
Journal:  Anal Biochem       Date:  2016-12-11       Impact factor: 3.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.